Prof. Chris Chiu is Professor of Infectious Diseases in the Department of Infectious Disease at Imperial College London. He is an infectious diseases physician and immunologist with internationally recognized expertise in respiratory viral infections, human challenge studies, mucosal immunity and vaccine development. His research focuses on the pathogenesis and protective immunity of respiratory viruses, including …
Archives du type de publication : Team Showcase
Pr. Paul G. Thomas
Paul G. Thomas, PhD is Professor and Program Head of the Immunology and Vaccine Development Program within the Vaccine and Infectious Disease Division at Fred Hutch Cancer Center, where he also holds the title of Bezos Family Distinguished Scholar in Viruses and Vaccines. He is a viral immunologist with deep expertise in respiratory viruses, T-cell …
Dr. Philipp Mudd
Philip Mudd, MD, PhD is Assistant Professor of Emergency Medicine at Washington University in St. Louis School of Medicine and Associate Director of the Center for Vaccines & Immunity to Microbial Pathogens. He is a practicing emergency physician and physician-scientist with expertise in translational virology, immunology and respiratory viral infections. His laboratory focuses on human …
Prof. Odile Launay, MD, PhD
Odile Launay is Professor of Infectious diseases at the University of Paris. She is the Director of the Clinical Investigation Center in Vaccinology (CIC Cochin Pasteur), the only French clinical investigation center dedicated to vaccinal research based in Paris, since it is creation in 2005 and Coordinator of the French Innovative Clinical Network in Vaccinology …
Frédéric Cren
Frédéric Cren is a biopharmaceutical executive, entrepreneur and co-founder of Inventiva, a clinical-stage biotechnology company listed on Euronext Paris and Nasdaq. He brings over 30 years of international leadership experience in biotech company creation, corporate strategy, financing, business development, R&D leadership and public-market governance. He served as Chief Executive Officer of Inventiva from the company’s …
Charlotte Primard
Charlotte has nearly 20 years of experience in non-clinical vaccine development, with expertise in immunology, vaccine mechanism of action, and preclinical evaluation of efficacy and safety. At Osivax, she leads outsourced preclinical activities, and supports vaccine programs by fostering strong cross-functional collaborations with teams in analytics, formulation, and immunology. Prior Experience: • Preclinical Studies – …
Florian Sourd
Florian has over 10 years of experience in corporate finance and financial services. Florian was involved more specifically in healthcare transactions for diagnostic companies and healthcare provider group. Prior experience: • Manager in Transaction Services, Deloitte (2015-2019) • Chief Financial Officer, OnyxT+ (2014-2015) • Senior in Financial Audit, EY (2012-2014) • M&A Analyst, BNP Paribas …
Vincent Monchois
Vincent has over 20 years of experience in bioprocess development and manufacturing, with deep expertise spanning recombinant proteins, monoclonal antibodies, vaccines and gene therapies. He has held senior leadership roles in biotech and CDMO environments, where he managed cross-functional teams, led large-scale CMC programs from early discovery to late-stage clinical supply, and supported global regulatory …
Dr. Otfried Kistner
Dr. Otfried Kistner is a Senior Consultant and Independent Vaccine Expert based in Vienna, Austria. He brings extensive expertise in virology, vaccine development, clinical serology, immunology, regulatory affairs, and biological manufacturing. Throughout his career, he has held senior scientific and virology leadership positions at Baxter BioScience and Baxter Innovations, contributing to the development of viral …
Prof. Pierre Vandamme, MD, PhD
Prof. Pierre Van Damme is the former Chairman of the Vaccine & Infectious Disease Institute (VAXINFECTIO) at the University of Antwerp, and head of the Centre for the Evaluation of Vaccination with more than 25 years of experience in vaccinology Expertise: • Conducted more than 350 vaccine trials at the Center for the Evaluation of …